Cagrilintide
Every GLP-1 the FDA has approved, and the active ingredient inside each one.
Definition
Novo Nordisk's long-acting amylin analog — a different receptor pathway from GLP-1 entirely, signaling satiety through the brainstem. Studied alone at 11.5% weight loss over 68 weeks in REDEFINE 1, and as the second half of CagriSema.
CagriSema REDEFINE trial results →
GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature. Not one of them is an AI-generated summary.
Other terms under Drugs and brands
Where the evidence lives
- CagriSema REDEFINE trial results
- The full GLP-1 glossary (149 terms, 8 categories)
- Research articles — written from primary sources
- Tools and calculators
- Compare GLP-1 telehealth providers